Despite a surge in investor interest, UK life sciences remains a very niche real estate sub-sector. For the investment proposition to stack-up, the underlying occupier fundamentals must repay the risks associated with investing in an emerging sector. Despite some challenges, we believe this market offers very strong risk-adjusted returns for early-mover investors who can demonstrate a deep understanding of the underlying occupier market and build long-term relationships with key growth tenants.
Want more insights?
Want more insights?
Subscribe to receive the latest private markets perspectives and insights across all sectors directly to your inbox.
Make an inquiry
Fill in an inquiry form and leave your details – we’ll be back in touch.
Introducing our leadership team
Meet the members of the team responsible for UBS Asset Management’s strategic direction.
